VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $440,368 | -67.0% | 101,941 | -49.7% | 0.00% | 0.0% |
| Q2 2023 | $1,335,845 | +101485.2% | 202,708 | +4.7% | 0.00% | -50.0% |
| Q1 2023 | $1,315 | -3.9% | 193,608 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $1,368 | -99.9% | 185,123 | +5.4% | 0.00% | -33.3% |
| Q3 2022 | $1,735,000 | -9.1% | 175,642 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $1,908,000 | +2.0% | 175,028 | +5.8% | 0.00% | +50.0% |
| Q1 2022 | $1,871,000 | -29.3% | 165,417 | -1.9% | 0.00% | -33.3% |
| Q4 2021 | $2,645,000 | -9.9% | 168,566 | -1.6% | 0.00% | -25.0% |
| Q3 2021 | $2,936,000 | -28.8% | 171,309 | -10.6% | 0.00% | -20.0% |
| Q2 2021 | $4,124,000 | +36.7% | 191,724 | -4.6% | 0.01% | +25.0% |
| Q1 2021 | $3,017,000 | +14.1% | 200,871 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $2,644,000 | +49.3% | 201,180 | +9.8% | 0.00% | +33.3% |
| Q3 2020 | $1,771,000 | -22.2% | 183,307 | -7.8% | 0.00% | -25.0% |
| Q2 2020 | $2,275,000 | +25.1% | 198,880 | +13.3% | 0.00% | 0.0% |
| Q1 2020 | $1,818,000 | -35.7% | 175,530 | +1.8% | 0.00% | -20.0% |
| Q4 2019 | $2,829,000 | +30.2% | 172,367 | +5.4% | 0.01% | +25.0% |
| Q3 2019 | $2,173,000 | -2.8% | 163,597 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $2,235,000 | -19.0% | 158,602 | +5.8% | 0.00% | -20.0% |
| Q1 2019 | $2,759,000 | -29.2% | 149,949 | +0.6% | 0.01% | -37.5% |
| Q4 2018 | $3,896,000 | +24.0% | 149,117 | +8.9% | 0.01% | +33.3% |
| Q3 2018 | $3,142,000 | +220.0% | 136,921 | +165.6% | 0.01% | +200.0% |
| Q2 2018 | $982,000 | +38.1% | 51,551 | +22.2% | 0.00% | +100.0% |
| Q1 2018 | $711,000 | +8.2% | 42,186 | -2.3% | 0.00% | 0.0% |
| Q4 2017 | $657,000 | -28.5% | 43,196 | -15.8% | 0.00% | -50.0% |
| Q3 2017 | $919,000 | +11.1% | 51,321 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $827,000 | +33.0% | 50,721 | +14.2% | 0.00% | +100.0% |
| Q1 2017 | $622,000 | -9.1% | 44,422 | +3.6% | 0.00% | -50.0% |
| Q4 2016 | $684,000 | +3.6% | 42,872 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $660,000 | +32.8% | 39,684 | -10.7% | 0.00% | +100.0% |
| Q2 2016 | $497,000 | +30.1% | 44,434 | -2.8% | 0.00% | 0.0% |
| Q1 2016 | $382,000 | -7.5% | 45,693 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $413,000 | -12.7% | 44,408 | +6.0% | 0.00% | -50.0% |
| Q3 2015 | $473,000 | -10.4% | 41,893 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $528,000 | +47.1% | 41,610 | +7.7% | 0.00% | +100.0% |
| Q1 2015 | $359,000 | -13.7% | 38,645 | +33.2% | 0.00% | 0.0% |
| Q4 2014 | $416,000 | +34.6% | 29,020 | -2.6% | 0.00% | 0.0% |
| Q3 2014 | $309,000 | -35.9% | 29,795 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $482,000 | +4.1% | 29,795 | +4.5% | 0.00% | 0.0% |
| Q1 2014 | $463,000 | +25.1% | 28,522 | -4.3% | 0.00% | 0.0% |
| Q4 2013 | $370,000 | +20.5% | 29,802 | +6.5% | 0.00% | 0.0% |
| Q3 2013 | $307,000 | +42.8% | 27,992 | +5.3% | 0.00% | 0.0% |
| Q2 2013 | $215,000 | – | 26,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |